| |
| |
|
| Insider
Information: |
Helsel Dave |
| Relationship: |
|
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
41,505 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,308,228 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,505 |
|
|
| Total
Value |
$1,308,228 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -152.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP, Global Manufactur... |
2015-04-13 |
13,216 |
2012-04-10 |
0 |
Premium* |
|
|
Angiodynamics Inc |
ANGO |
|
2023-07-21 |
28,289 |
2019-07-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2013-10-25 |
4 |
D |
$41.09 |
$10,108 |
D/D |
(246) |
9,670 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-07-18 |
4 |
D |
$24.76 |
$10,325 |
D/D |
(417) |
17,764 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2020-12-18 |
4 |
D |
$14.29 |
$10,475 |
D/D |
(733) |
22,615 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2014-04-11 |
4 |
D |
$32.48 |
$10,653 |
D/D |
(328) |
9,342 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2019-12-18 |
4 |
D |
$15.57 |
$11,460 |
D/D |
(736) |
16,422 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2015-04-13 |
4 |
D |
$43.73 |
$13,206 |
D/D |
(302) |
13,216 |
0 |
- |
|
| HAE |
Haemonetics Corp |
VP, Global Manufacturing |
• – – |
2013-04-11 |
4 |
D |
$41.12 |
$13,487 |
D/D |
(328) |
6,584 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-19 |
4 |
D |
$8.92 |
$14,049 |
D/D |
(1,575) |
31,085 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-07-14 |
4 |
D |
$26.43 |
$16,915 |
D/D |
(640) |
18,475 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-08-12 |
4 |
D |
$27.29 |
$21,505 |
D/D |
(788) |
23,719 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2022-07-07 |
4 |
D |
$20.54 |
$25,120 |
D/D |
(1,223) |
25,131 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-19 |
4/A |
D |
$8.92 |
$31,015 |
D/D |
(3,477) |
34,462 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2023-01-31 |
4 |
S |
$12.95 |
$59,997 |
D/D |
(4,633) |
19,189 |
0 |
% |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2022-04-28 |
4 |
S |
$22.44 |
$78,832 |
D/D |
(3,513) |
22,874 |
0 |
% |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-04-14 |
4 |
S |
$23.93 |
$83,755 |
D/D |
(3,500) |
19,115 |
0 |
% |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-08-12 |
4/A |
D |
$27.29 |
$91,340 |
D/D |
(3,347) |
29,881 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-10-20 |
4 |
S |
$27.97 |
$97,727 |
D/D |
(3,494) |
26,387 |
0 |
% |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2022-07-29 |
4 |
S |
$22.44 |
$112,200 |
D/D |
(5,000) |
23,822 |
0 |
% |
|
43 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
